laitimes

Jinsrui Vigorous Biologics, Aibo Biologics and Watson Biologics reached a cooperation in the registration and declaration of mRNA new crown vaccines and commercial production

author:Interface Alerts

Jinsrui Vigorous Biologics, Together with Abbott Biologics and Watson Biologics, the three parties have reached a cooperation on the registration (BLA) declaration and commercial production of biological products for the domestic mRNA New Crown Vaccine Project (ABO-028M). Watson Bio is the main applicant for the ABO-028M project, and Jinsrui Boom Biotech will provide exclusive services for the commercial production of plasmids in the ABO-028M project.

The project is the first batch of mRNA new crown vaccine projects in China, and has carried out international multi-center clinical trials, and has obtained approval for phase III clinical trials issued by the three national drug regulatory departments of Mexico, Indonesia and Nepal.

Read on